NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS 2017 - REG 104 Transitional provision relating to the National Health (Pharmaceutical Benefits) Amendment (2024 Measures No. 1) Regulations 2024 [100%]
(From Commonwealth Consolidated Regulations; 1 January 2017; 5 KB)   

NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS 2017 - REG 30 Variation of application of determination of maximum number of repeats or maximum number of quantity of units [50%]
(From Commonwealth Consolidated Regulations; 1 January 2017; 4 KB)   

NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS 2017 - NOTES [10%]
(From Commonwealth Consolidated Regulations; 1 January 2017; 89 KB)   

NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS 2017 - REG 5 Interpretation [10%]
(From Commonwealth Consolidated Regulations; 1 January 2017; 41 KB)